KRAS and skin neoplasm: Combining the point mutant alleles p53LSL-R172H and K-rasLSL-G12D has been shown to increase skin tumour formation, accelerate tumour progression, and induce metastasis when compared with single deletion of p53 or over-expression of K-ras [13].